| Key Financial Ratios of JB Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
42.00 |
35.07 |
50.29 |
46.71 |
57.85 |
|
| Diluted EPS (Rs.) |
41.16 |
34.30 |
49.69 |
46.71 |
57.85 |
|
| Cash EPS (Rs.) |
52.61 |
43.73 |
64.73 |
55.94 |
66.57 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
216.94 |
185.98 |
315.65 |
272.21 |
233.75 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
216.94 |
185.98 |
315.65 |
272.21 |
233.75 |
|
| Dividend / Share(Rs.) |
15.50 |
12.25 |
17.75 |
16.50 |
16.50 |
|
| Revenue from Operations/Share (Rs.) |
239.14 |
212.55 |
372.74 |
283.36 |
244.82 |
|
| PBDIT/Share (Rs.) |
67.62 |
58.90 |
87.02 |
70.85 |
86.47 |
|
| PBIT/Share (Rs.) |
56.93 |
50.19 |
72.55 |
61.62 |
77.75 |
|
| PBT/Share (Rs.) |
56.34 |
47.57 |
68.11 |
60.98 |
76.82 |
|
| Net Profit/Share (Rs.) |
41.92 |
35.01 |
50.26 |
46.71 |
57.85 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
28.27 |
27.71 |
23.34 |
25.00 |
35.32 |
|
| PBIT Margin (%) |
23.80 |
23.61 |
19.46 |
21.74 |
31.76 |
|
| PBT Margin (%) |
23.55 |
22.38 |
18.27 |
21.52 |
31.37 |
|
| Net Profit Margin (%) |
17.52 |
16.47 |
13.48 |
16.48 |
23.63 |
|
| Return on Networth / Equity (%) |
19.32 |
18.82 |
15.92 |
17.16 |
24.74 |
|
| Return on Capital Employed (%) |
24.66 |
25.18 |
18.95 |
21.73 |
31.74 |
|
| Return on Assets (%) |
15.61 |
13.88 |
11.20 |
14.22 |
20.31 |
|
| Total Debt/Equity (X) |
0.00 |
0.12 |
0.22 |
0.01 |
0.01 |
|
| Asset Turnover Ratio (%) |
0.92 |
0.89 |
0.96 |
0.92 |
85.98 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.04 |
2.09 |
2.75 |
3.32 |
4.74 |
|
| Quick Ratio (X) |
2.24 |
1.53 |
1.99 |
2.31 |
3.83 |
|
| Inventory Turnover Ratio (X) |
7.98 |
1.92 |
2.13 |
1.91 |
6.78 |
|
| Dividend Payout Ratio (NP) (%) |
36.32 |
28.89 |
32.80 |
35.32 |
16.42 |
|
| Dividend Payout Ratio (CP) (%) |
28.94 |
23.13 |
25.47 |
29.49 |
14.27 |
|
| Earnings Retention Ratio (%) |
63.68 |
71.11 |
67.20 |
64.68 |
83.58 |
|
| Cash Earnings Retention Ratio (%) |
71.06 |
76.87 |
74.53 |
70.51 |
85.73 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
25,163.36 |
25,876.74 |
15,721.50 |
12,160.10 |
9,688.08 |
|
| EV/Net Operating Revenue (X) |
6.76 |
7.84 |
5.45 |
5.55 |
5.12 |
|
| EV/EBITDA (X) |
23.90 |
28.31 |
23.35 |
22.21 |
14.50 |
|
| MarketCap/Net Operating Revenue (X) |
6.78 |
7.76 |
5.29 |
5.56 |
5.12 |
|
| Retention Ratios (%) |
63.67 |
71.10 |
67.19 |
64.67 |
83.57 |
|
| Price/BV (X) |
7.48 |
8.87 |
6.24 |
5.79 |
5.36 |
|
| Price/Net Operating Revenue |
6.78 |
7.76 |
5.29 |
5.56 |
5.12 |
|
| Earnings Yield |
0.03 |
0.02 |
0.03 |
0.03 |
0.05 |
|
Source : Dion Global Solutions Limited
